Literature DB >> 15880281

Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma.

Kazuaki Shimada1, Tsuyoshi Sano, Yoshihiro Sakamoto, Tomoo Kosuge.   

Abstract

Left hepatic trisegmentectomy has been performed for huge malignant tumors, but it is rarely applied in patients with hilar cholangiocarcinoma. Twelve consecutive patients (7 men and 5 women; mean age, 64 years) underwent left hepatic trisegmentectomy in our institution between January 2000 and December 2003. The preoperative management and postoperative outcomes of this surgical procedure were presented and retrospectively analyzed. Preoperative biliary drainage and portal vein embolization were performed in 6 patients (50%) and 9 patients (75%), respectively. The preoperative estimated volume ratio of the posterior segment /the whole liver was 44.8 +/- 7.0% (34.3-54.3), the plasma retention rate of indocyanine green at 15 minutes was 8.6 +/- 2.2% (4.7-13.7), and the serum total bilirubin level before surgery was 1.0 +/- 0.4 mg/dl (0.4-1.7). The serum total bilirubin level on the first postoperative day was 3.3 +/- 0.4 mg/dl (1.4-6.2). There was no hospital death or postoperative hepatic failure. The incidence of positive resectional margin was 25%. With biliary decompression and preoperative portal embolization techniques, left hepatic trisegmentectomy was a safe and curative resectional option for hilar cholangiocarcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 15880281     DOI: 10.1007/s00268-005-7704-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Portal embolization relieves persistent jaundice after complete biliary drainage.

Authors:  M Ijichi; M Makuuchi; H Imamura; T Takayama
Journal:  Surgery       Date:  2001-07       Impact factor: 3.982

2.  Poor prognoses following left hepatic trisegmentectomies for cancer.

Authors:  H Hasegawa; S Yamasaki; M Makuuchi; Y Shimamura; P Gunvén
Journal:  Jpn J Clin Oncol       Date:  1989-09       Impact factor: 3.019

3.  Left hepatic trisegmentectomy.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; P M Waterman; D Van Thiel; H S Diliz; A Dekker; K M Bron
Journal:  Surg Gynecol Obstet       Date:  1982-07

Review 4.  Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

Authors:  T Kosuge; J Yamamoto; K Shimada; S Yamasaki; M Makuuchi
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

5.  Hilar cholangiocarcinoma evaluated by three-dimensional CT cholangiography and rotating cine cholangiography.

Authors:  H Furukawa; K Sano; T Kosuge; K Shimada; J Yamamoto; R Iwata; N Moriyama
Journal:  Hepatogastroenterology       Date:  2000 May-Jun

6.  Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies.

Authors:  S Miyagawa; M Makuuchi; S Kawasaki; K Hayashi; H Harada; H Kitamura; H Seki
Journal:  World J Surg       Date:  1996-01       Impact factor: 3.352

7.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

8.  Hepatic trisegmentectomy for 29 patients with huge liver neoplasms.

Authors:  Jing-An Rui; Li Zhou; Shao-Bin Wang; Shu-Guang Chen; Xue Wei; Kai Han; Ning Zhang; Hai-Tao Zhao; Xin Yang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2002-05

Review 9.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma.

Authors:  M Nagino; Y Nimura; J Kamiya; S Kondo; K Uesaka; Y Kin; Y Kutsuna; N Hayakawa; H Yamamoto
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

View more
  9 in total

1.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

2.  Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma.

Authors:  Lei-Bo Xu; Chao Liu; Guo-Quan Gao; Xian-Huan Yu; Rui Zhang; Jie Wang
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

Review 3.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

4.  Radical surgery of left-sided klatskin tumors.

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality.

Authors:  Norihiko Furusawa; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Hiroaki Motoyama; Sin-ichi Miyagawa
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

6.  The Pitfalls of Left Trisectionectomy or Central Bisectionectomy for Biliary Cancer: Anatomical Classification Based on the Ventral Branches of Segment VI Portal Vein Relative to the Right Hepatic Vein.

Authors:  Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  J Gastrointest Surg       Date:  2017-06-30       Impact factor: 3.452

7.  Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients.

Authors:  Li Jingdong; Xiong Yongfu; Gang Yang; Xu Jian; Huang Xujian; Liu Jianhua; Zhao Wenxing; Qin Renyi; Yin Xinming; Zheng Shuguo; Liang Xiao; Peng Bin; Zhang Qifan; Li Dewei; Tang Zhao-Hui
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

8.  Repair of a post-hepatectomy posterior sectoral duct injury secondary to anomalous bile duct anatomy using a novel combined surgical-interventional radiologic approach.

Authors:  Beth-Ann Shanker; Oliver S Eng; Vyacheslav Gendel; John Nosher; Darren R Carpizo
Journal:  Case Rep Surg       Date:  2013-09-12

Review 9.  Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure.

Authors:  Shuai Xiang; Wan Yee Lau; Xiao-ping Chen
Journal:  Int J Colorectal Dis       Date:  2014-11-08       Impact factor: 2.571

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.